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Abstract
Background: The cross-sectional area of the subclavian vein (csSCV) is an important factor determining the
success rate of SCV catheterization. The head-down position increases the csSCV. However, the effects of
lateral tilting on subclavian venous cross-sectional area have not yet been explored. In this trial, we test our
hypothesis that ipsilateral tilt during right SCV catheterization may significantly increase the csSCV by
impeding blood flow to the heart, thereby increasing the primary venipuncture success rate and reducing the
complication rate and procedure time.
Methods/design: This is a two-staged, prospective, randomized, controlled trial conducted on 237
neurosurgical patients requiring SCV catheterization. Seventeen patients in stage I will be placed in supine,
20° ipsilateral tilt, and 20° contralateral tilt positions in random order. The right csSCV will be measured using
ultrasonography at each position. In stage II, 220 patients will be randomly assigned to the ipsilateral tilt
group (n = 110) and supine group (n = 110) according to the position for right SCV catheterization. Data on
catheterization-related characteristics and complications will be collected during and after catheterization. The
primary outcome measures are the right csSCV for stage I and primary venipuncture success rate for stage II.
The secondary outcome measures for stage II are time to venipuncture, total catheterization time, first-pass
success rate, and complications, such as arterial puncture, hematoma, pneumothorax, air embolism, and
catheter misplacement.
Discussion: This is the first trial to investigate the effects of the ipsilateral tilt position on right SCV
catheterization. We will attest the beneficial effects of the ipsilateral tilt position on the csSCV and the
primary venipuncture success rate during right SCV catheterization. Furthermore, comparisons of the first-pass
success rate, complications, and total catheterization time during SCV catheterization in the ipsilateral tilt
position vs. the supine position will help us determine which position is better for safe and easy SCV
catheterization.
Trial registration: ClinicalTrials.gov, ID: NCT03296735. Registered on 25 September 2017 for stage I;
NCT03303274 Registered on 6 October 2017 for stage II.
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Background
Central venous catheterization has been utilized in oper-
ating rooms and intensive care units for various pur-
poses, including central venous pressure monitoring,
fluid and drug administration, and parenteral nutrition.
The internal jugular, subclavian, and femoral veins are
used for vascular access. Central venous catheterization
through the subclavian vein (SCV) is more comfortable
for the patient, with a lower risk for infection but higher
risk for pneumothorax compared to femoral and internal
jugular venous catheterization [1–3].
The cross-sectional area of the SCV (csSCV) is an im-
portant determinant of the success rate of SCV
catheterization. Body position can affect the csSCV. Previ-
ous studies have shown that the Trendelenburg position in-
creases csSCV [4–7], while contralateral head rotation and
placement of a shoulder-roll decreases it [8, 9]. However,
the effects of lateral tilt on the csSCV have not been ex-
plored. Ipsilateral tilting may expand subclavian venous
cross-sectional area by impeding blood flow to the heart,
whereas contralateral tilting may reduce the area by venous
collapse. Therefore, we hypothesized that the ipsilateral tilt
position during right SCV catheterization might signifi-
cantly increase the csSCV and thereby increase the primary
venipuncture success rate and reduce the complication rate
and procedure time compared to the supine position.
In this trial, we will compare the right csSCV among su-
pine, ipsilateral tilt, and contralateral tilt positions to deter-
mine the beneficial effects of the ipsilateral tilt position on
the csSCV, and will assess the venipuncture success rate at
the first needling attempt, number of needling attempts for
venipuncture, venipuncture time, total catheterization time,
first-pass success rate, and complication rate during
right-sided SCV catheterization in the supine position vs.
the ipsilateral tilt position to determine which position is a
better position for safe and easy SCV catheterization.
Methods
Study design
This is a two-staged, prospective, single-blind,
single-center, superiority, randomized controlled trial.
Stage I has a crossover design and stage II has a parallel
randomized assignment. This study was approved by the
Institutional Review Board of Seoul National University
Hospital (number: 1707–110–871, date: 11 September
2017) and registered at ClinicalTrials.gov (NCT03296735
for Stage I and NCT03303274 for stage II). This trial is
still being conducted at Seoul National University Hos-
pital. The study protocol is reported according to the
Standard Protocol Items: Recommendations for Interven-
tional Trials guidelines (Fig. 1 and Additional file 1). In
addition, the final report of this trial will adhere to the
Consolidated Standards of Reporting Trials (CONSORT)
Statement.
Study population
Adult patients (aged 20–79 years), who are scheduled to
undergo elective craniotomy to remove a brain tumor
and who require SCV catheterization during the surgery,
will be enrolled in this trial. The exclusion criteria are
patient refusal; skin infection at the needle puncture site;
a known SCV abnormality, such as an anatomical anom-
aly or thrombus in the SCV; tricuspid valve vegetation;
anticoagulant administration; chemoport or pacemaker
in situ in the SCV; having undergone right mastectomy
or pneumonectomy.
Ethics, consent, and permission
This study follows the tenets of the Declaration of
Helsinki, and written informed consent will be obtained
from all participants 1 day before the surgery.
Withdrawal, dropout, and discontinuation
Participants will be withdrawn from the trial and ex-
cluded from the data analysis if they voluntarily with-
draw informed consent at any time during the study
period. The trial will be discontinued if serious adverse
events, such as intractable cardiac arrhythmia, arterial
puncture, and evident pneumothorax, and massive air
embolism, occur in any patient during the procedure.
Any unpredicted adverse events that occurred during
the trial will be reported to the Institutional Review
Board. The data analyses will be conducted according to
the intention-to-treat principle.
Randomization
The trial follows the CONSORT flow chart from
randomization to analysis (Fig. 2). The randomization ta-
bles used for stage I and stage II will be prepared before pa-
tient enrollment by an anesthesiologist blinded to this trial.
An anesthetic nurse who is not involved with the trial will
maintain the randomization tables in sealed opaque enve-
lopes. Based on the order of the randomization table, the
anesthetic nurse will notify the position sequence in stage I
and group allocation in stage II to investigators after eligible
patients enter the operating room.
In stage I with a crossover design, the patients will be
placed in three different positions (supine, ipsilateral tilt,
and contralateral tilt) and the right csSCV will be mea-
sured at each position. A random sequence for the three
positions is made using the “RAND function” in Excel.
In stage II, patients will be randomly assigned to two
groups (supine and ipsilateral tilt groups) with a 1:1 ratio
according to the type of position for right SCV
catheterization. A random sequence with 4 or 6 random
block sizes is created using online random allocation
software (http://mahmoodsaghaei.tripod.com/Softwares/
randalloc.html).
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Blinding and confidentiality
This is a single-blind trial. Therefore, attending anesthe-
siologists (HCL and HPP) collecting the data and practi-
tioners performing SCV catheterization are aware of the
randomized position order in stage I and the group allo-
cation in stage II.
All patients will be assigned as a study identification
number, and the study data will be collected under this
number. None of the information that reveals the pa-
tient’s identity, including name, social security number,
and hospital chart number will be recorded. The data
will be kept confidential until the data analyses are com-
pleted by the analyzers (DEJ and HKY). After study
completion, the data will be stored for 3 years and then
discarded according to the Korean Enforcement Rule of
Bioethics and Safety Act.
Study protocol
The first 17 patients enrolled in the study will be sub-
jected to stage I, in which the right csSCV will be mea-
sured in the supine, 20° ipsilateral tilt, and contralateral
tilt positions. After inducing general anesthesia, the pa-
tients will be placed in the three different positions
based on the order predetermined by the randomized
table. The tilted positions will be achieved by tilting the
operating tables by 20° ipsilaterally or contralaterally.
The patient’s head and body will be placed in a neutral
position in the supine as well as in the two tilted posi-
tions. Each position will be maintained for 1 min and
the right csSCV will be measured using a 4.5–8-MHz
linear ultrasound probe (Vscan Extend, GE Healthcare,
Seoul, South Korea) at the mid-point of the right clav-
icle. The SCV is identified by loss of pulsatility, com-
pressibility, and a change in the area corresponding to
respiration. An image of the right csSCV will be cap-
tured at the end of expiration, and the area will be mea-
sured using image-processing software (ImageJ, National
Institutes of Health, Bethesda, MD, USA).
The next 220 patients will be subjected to stage II and
randomly placed in either the supine or 20° ipsilateral
tilted position for at least 1 min for right SCV
catheterization. The head and body will remain neutral
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in the supine and ipsilateral tilted positions without
slight Trendelenburg down. Surgical belts will be tightly
strapped around the flanks and knees in the 20° ipsilat-
eral tilted position. In addition, assistants will hold the
head and body to prevent an ipsilateral head tilt and the
risk of falling down, respectively. No manipulation,
including placement of a shoulder-roll or pulling of the
ipsilateral arm, will be used for SCV catheterization.
After anesthetic induction, the right SCV catheterization
will be performed using the Seldinger technique and the
anatomical landmark-based method by anesthesiologists
who have experienced at least 50 cases of SCV
catheterization. The skin area around the right clavicle is
disinfected with a solution (72% alcohol plus 2% chlor-
hexidine). A large, adhesive, disposable drape is aseptic-
ally applied to prevent migration of the drape from the
procedural field and maintain sterility throughout the
procedure. Thereafter, patients are placed in the supine
or 20° ipsilateral tilted position for SCV catheterization.
The skin puncture point is 1 cm lateral and 1 cm infer-
ior from the inferior border at the mid-point of the clav-
icle. The skin is punctured with an introducer needle
and the needle is advanced towards the SCV for
venipuncture. When venipuncture is confirmed with
regurgitation of venous blood into the syringe attached
to the needle, a guidewire is advanced through the intro-
ducer needle. A dilator is advanced through the guide-
wire and removed to provide easy advancement of a 7 Fr
double-lumen central venous catheter (Arrow Inter-
national Inc., Reading, PA, USA). SCV catheterization is
completed when the central venous catheter is inserted
at a depth of 13–16 cm, the guidewire is removed, and
the indwelling catheter is secured. Patients will receive
positive pressure mechanical ventilation before skin
puncture with the needle. Mechanical ventilation will be
stopped at the time of skin puncture and then resumed
after insertion of the indwelling catheter.
If the first attempt at venipuncture fails, the needle is
slowly retreated until the needle tip is in subcutaneous
tissue. The angle and depth of the needle will be
adjusted for the next needle passage, which is dependent
on the practitioner’s judgment. If the first practitioner
fails to puncture the SCV after three needling attempts,
the second practitioner will attempt venipuncture. If the
second practitioner also fails at venipuncture after three
needling attempts, the case will be classified as a failed
SCV catheterization. In addition, if arterial puncture or
air aspiration is evidently detected during the procedure,
failure of the SCV catheterization will be considered. In
cases of failed SCV catheterization, the central venous
catheter will be placed in another central vein, such as
the internal jugular or femoral vein.
SCV catheterization-related data, such as the number of
needling attempts for venipuncture and total catheterization
time, will be collected during the procedure. Clinical signs
of air embolism, such as abruptly decreased end tidal
Fig. 2 Consolidated Standards of Reporting Trials (CONSORT) flow chart
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carbon dioxide concentration and blood pressure, will be
noted. Hematoma, a complication of catheterization, will be
detected by the attending anesthesiologists primarily
through inspection and manipulation of the puncture site
and using ultrasonography if necessary. A chest radiograph
will be obtained immediately after surgery to detect
catheterization-related complications, such as pneumo-
thorax and misplacement of the catheter tip.
Measurements
Demographic data will be collected before SCV
catheterization in the stage I patients. The right csSCV
will be measured in the supine, 20° ipsilateral tilt, and
contralateral tilt positions.
SCV catheterization-related data and demographics will
be collected from the stage II patients. The data collected
includes the success rate of SCV puncture at the first need-
ling attempt (primary venipuncture success rate), the num-
ber of needling attempts for successful venipuncture,
venipuncture time (time from skin puncture to venous
blood aspiration), total catheterization time (time from skin
puncture to completion of indwelling catheter insertion),
first-pass success rate of catheterization (success rate of
catheterization at the first attempt without any complica-
tions and technical disturbances, such as failed venous
puncture or difficulties inserting the guidewire, dilator, or
catheter), overall success rate of catheterization, the rate of
puncture on the anterior wall of the SCV, the incidence of
rescue mechanical ventilation, and the number of manipula-
tion attempts to insert the guidewire, dilator, and catheter.
Data on catheterization-related complications, includ-
ing arterial puncture, hematoma, pneumothorax/hemo-
thorax, air embolism, and misplacement of the catheter
tip (placement of the catheter tip in a location other
than the superior vena cava or right atrium), will be col-
lected during and after the procedure.
Study endpoints
The primary endpoint measures are the csSCV in stage I
and the primary venipuncture success rate in stage II. The
secondary endpoint measures in stage II are the number of
needling attempts for successful venipuncture, venipuncture
time, total catheterization time, first-pass success rate, and
complication rate.
Sample size
The right csSCV in the supine position for stage I was
reported to be 0.93 ± 0.17 cm2 in a previous study [10].
At an alpha level of 0.017 and a beta level of 0.2, a mini-
mum of 15 patients are required to confirm a 15% in-
crease in the csSCV in the ipsilateral tilt position
compared to the supine position in the same patient.
Considering a 10% dropout rate, 17 patients are needed
for stage I.
In stage II, the primary venipuncture success rate has
been reported to be 74.5% in the supine position during
right SCV catheterization [11]. At the alpha level of 0.05
and a beta level of 0.2, at least 100 patients per group
are needed to determine a 15% increase in primary
venipuncture success rate in the ipsilateral tilt position.
Assuming a 10% dropout rate, 110 patients are needed
in each group.
Statistical analysis
Statistical analyses will be performed with SPSS 21.0
(SPSS Inc., Chicago, IL, USA) and Med Calculator
(MedCalc Software, Ostend, Belgium). All continuous
variables will be expressed as mean ± standard deviation
or median (interquartile range) based on results of the
Shapiro-Wilk test. All categorical variables will be
expressed as numbers (percent).
In stage I, the cross-sectional areas in the three different
positions will be compared to the paired t test or
Wilcoxon signed-rank test according to the results of the
Shapiro-Wilk test. The alpha level of 0.017 (0.05/3) is set
to compensate for multiple comparisons (× 3). In stage II,
the number of needling attempts for venipuncture,
venipuncture time, and total catheterization time between
the two groups will be analyzed with the Student’s t test or
the Mann-Whitney test. The primary venipuncture
success rate, first-pass success rate, and complication rate
will be analyzed with the chi-square test or Fisher’s exact
test. A P value < 0.05 is considered significant.
Discussion
This is the first trial to investigate the effects of ipsilateral
tilt position on right SCV catheterization by comparing
the csSCV and catheterization-related characteristics be-
tween the ipsilateral tilt position and the supine position.
Body position can change the csSCV. The Trendelenburg
position increases the csSCV [4–7], whereas contralateral
rotation of the head and placement of a roll padding under
the shoulder decreases it [8, 9]. However, the effects of ipsi-
lateral tilt position on the csSCV during right SCV
catheterization have not been clarified. In this trial, we hy-
pothesized that the ipsilateral tilt position during right SCV
catheterization would expand the csSCV by impeding
blood flow to the heart. We will test our hypothesis by
comparing the right csSCV among three different positions
(supine, ipsilateral tilt, and contralateral tilt positions).
The csSCV is an essential factor for successful
SCV catheterization, particularly when the anatomic
landmark-based technique is used. A large csSCV leads to
a high success rate of SCV puncture at the first needling
attempt, which can increase the first-pass success rate of
SCV catheterization and decrease the chance of
catheterization-related complications, such as arterial
puncture, hematoma and pneumothorax, due to repeated
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needling. We will compare the primary venipuncture suc-
cess rate, first-pass success rate, catheterization-related
complications, and total catheterization time during right
SCV catheterization between the supine and ipsilateral tilt
positions to verify the clinical significance of the right
csSCV on SCV catheterization.
With respect to mechanical ventilation during central
venous catheterization, there is no well-defined consensus.
Pneumothorax is a common SCV catheterization-related
complication. A recent study showed that the incidence of
pneumothorax during infraclavicular SCV catheterization
was similar between patients with positive pressure ventila-
tion and those without [11]. In contrast, another study re-
ported that positive pressure ventilation was associated
with the high risk of pneumothorax [12]. In this study
protocol, mechanical ventilation will be paused during SCV
catheterization to minimize the risk of pneumothorax.
In general, the slight-Trendelenberg-down position is
often recommended to engorge the subclavian vein and
decrease the risk of air embolism during SCV
catheterization. In this study, however, SCV
catheterization will be carried out in the supine and ipsi-
lateral tilt position without slight Trendelenberg down.
Because patients undergoing craniotomy for brain tumor
removal are enrolled in this study, we will need to elimin-
ate the possibility of an increase in intracranial pressure
associated with the slight-Trendelenberg-down position.
Placing a patient in the ipsilateral tilt position using the
operating table is a simple maneuver that can be easily
done in an operating room. In this trial, we expect that
the ipsilateral tilt position may be advantageous over the
supine position during right SCV catheterization in terms
of the success rate of catheterization, procedure time, and
catheterization-related complications.
Two problems are expected when performing right SCV
catheterization in the ipsilateral tilt position: there is a risk
of falling and a tendency of the head to tilt towards the ip-
silateral tilt position. Surgical belts strapped around the
body of the patient and assistance to place the body and
head of the patient in the neutral position are additionally
needed to prevent such events. For the ipsilateral tilt
group, we additionally pay attention to the attachment of
a sterile disposable drape to maintain sterility throughout
the procedure. After 20° ipsilateral tilt, the skin puncture
site tends to fall below a practitioner’s comfort zone.
Therefore, the surgical table is elevated until the practi-
tioner can easily access the puncture site. Also, there is a
possibility that the ipsilateral tilt position makes
venipuncture difficult in some patients, especially those
with obesity. However, SCV catheterization in obese pa-
tients is difficult even in the supine position. A subgroup
analysis to evaluate the effect of body position on the
venipuncture rate in obese patients may be helpful in clin-
ical practice for increasing successful SCV catheterization.
In summary, in this trial, we will attest the beneficial
effects of the ipsilateral tilt position on the csSCV and
primary venipuncture success rate during right SCV
catheterization. Furthermore, comparisons of the first-pass
success rate, complications, and total catheterization time
during SCV catheterization in the ipsilateral tilt position vs.
the supine position will help clarify which position is safer
and easier for SCV catheterization.
Trial status
Patient recruitment commenced in October 2017 and is
still ongoing. It is anticipated that recruitment will be
completed in September 2018.
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Additional file 1: Standard Protocol Items: Recommendations for
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